[
  {
    "objectID": "about.html",
    "href": "about.html",
    "title": "About This Project",
    "section": "",
    "text": "This website presents a comprehensive analysis of 42 bacterial isolates from the KPC-31 resistome project, focusing on carbapenemase-producing Klebsiella pneumoniae and Escherichia coli."
  },
  {
    "objectID": "about.html#project-overview",
    "href": "about.html#project-overview",
    "title": "About This Project",
    "section": "",
    "text": "This website presents a comprehensive analysis of 42 bacterial isolates from the KPC-31 resistome project, focusing on carbapenemase-producing Klebsiella pneumoniae and Escherichia coli."
  },
  {
    "objectID": "about.html#data-source",
    "href": "about.html#data-source",
    "title": "About This Project",
    "section": "Data Source",
    "text": "Data Source\nDataset: Progetto 1 (KPC-31) versione 2.xlsx\nThe dataset includes: - 42 bacterial isolates - 155 variables covering: - Bacterial identification (species, MLST, capsular typing) - Antimicrobial susceptibility testing (MIC for ~26 antibiotics) - Resistance gene detection (36 genes) - Plasmid replicon typing (15 incompatibility groups)"
  },
  {
    "objectID": "about.html#methodology",
    "href": "about.html#methodology",
    "title": "About This Project",
    "section": "Methodology",
    "text": "Methodology\n\nBacterial Characterization\n\nSpecies identification: Standard microbiological methods\nMulti-locus sequence typing (MLST): Sequence type determination\nCapsular typing (KL): K-locus characterization\nWzi typing: Capsule synthesis region analysis\n\n\n\nAntimicrobial Susceptibility Testing\nMIC (Minimum Inhibitory Concentration) values determined for approximately 26 antibiotics including: - Beta-lactams (including carbapenems) - Beta-lactam/beta-lactamase inhibitor combinations (CAZ-AVI, PIP-TAZ) - Aminoglycosides - Quinolones - Colistin\nResistance Interpretation: - CAZ-AVI Susceptible: MIC â‰¤8 mg/L - CAZ-AVI Intermediate: MIC 9-16 mg/L - CAZ-AVI Resistant: MIC &gt;16 mg/L\n\n\nMolecular Analysis\n\nResistance Gene Detection\n36 resistance genes analyzed including: - Beta-lactamases: blaKPC-31, blaCTX-M-15, blaTEM, blaSHV variants, blaOXA - Aminoglycoside resistance: aac, aph, ant genes, armA (16S rRNA methylase) - Quinolone resistance: qnrB1, gyrA/ParC mutations - Other mechanisms: Sul1/Sul2 (sulfonamides), fosA (fosfomycin)\n\n\nPlasmid Typing\n15 incompatibility groups detected: - IncFIB(K), IncFII(K) - K. pneumoniae-specific IncF plasmids - IncX3 - Small mobilizable plasmid - IncR - Broad host range - IncN - Broad host range - Multiple other Inc groups\n\n\n\nData Analysis\nAll analyses performed using: - R version: 4.5.1 - Platform: Positron 2025.12.2 - Key packages: - tidyverse (v2.0.0) - data manipulation and visualization - readxl (v1.4.3) - Excel file import - ggplot2 (v4.0.1) - graphics - knitr and kableExtra - table formatting\n\n\nStatistical Methods\n\nDescriptive statistics (counts, percentages, medians)\nLog2 transformation for MIC visualization\nHierarchical clustering for resistance patterns\nChi-square and Fisherâ€™s exact tests where appropriate"
  },
  {
    "objectID": "about.html#limitations",
    "href": "about.html#limitations",
    "title": "About This Project",
    "section": "Limitations",
    "text": "Limitations\n\nSample size: Limited to 42 isolates\nCapsular typing: Only 23.8% (10/42) isolates have KL typing\nMissing data: Variable completeness across different data types\nPlasmid detection: 62% of isolates have no detectable Inc groups (possible chromosomal integration or novel plasmids)\nCross-sectional design: No temporal or longitudinal data available"
  },
  {
    "objectID": "about.html#key-definitions",
    "href": "about.html#key-definitions",
    "title": "About This Project",
    "section": "Key Definitions",
    "text": "Key Definitions\n\nMolecular Typing\n\nST (Sequence Type): Classification based on multi-locus sequence typing (MLST) of housekeeping genes\nKL (Capsular Type): Classification based on K-locus genetic structure\nHigh-risk clone: Globally disseminated sequence types associated with multidrug resistance and virulence\n\n\n\nResistance Mechanisms\n\nCarbapenemase: Enzyme that hydrolyzes carbapenem antibiotics (e.g., KPC-31)\nESBL: Extended-spectrum beta-lactamase (e.g., CTX-M-15)\n16S rRNA methylase: Enzyme conferring pan-aminoglycoside resistance (e.g., armA)\n\n\n\nPlasmid Biology\n\nInc group: Incompatibility group - plasmids classification based on replication systems\nHGT: Horizontal gene transfer - movement of genetic material between bacteria\nConjugation: Transfer of plasmids between bacteria via cell-to-cell contact"
  },
  {
    "objectID": "about.html#data-availability",
    "href": "about.html#data-availability",
    "title": "About This Project",
    "section": "Data Availability",
    "text": "Data Availability\nThe analysis code and this website are available on GitHub. The raw dataset is not publicly available due to potential patient privacy concerns."
  },
  {
    "objectID": "about.html#reproducibility",
    "href": "about.html#reproducibility",
    "title": "About This Project",
    "section": "Reproducibility",
    "text": "Reproducibility\nThis analysis is fully reproducible. All code used to generate the figures and tables is embedded in the Quarto documents and can be viewed using the â€œCodeâ€ buttons throughout the report."
  },
  {
    "objectID": "about.html#ai-assistance-disclosure",
    "href": "about.html#ai-assistance-disclosure",
    "title": "About This Project",
    "section": "AI Assistance Disclosure",
    "text": "AI Assistance Disclosure\n\n\n\n\n\n\nNote\n\n\n\nThis analysis was conducted with AI assistance (Databot in Positron) under human direction. All findings should be verified by qualified microbiologists and epidemiologists before clinical or public health decisions."
  },
  {
    "objectID": "about.html#contact",
    "href": "about.html#contact",
    "title": "About This Project",
    "section": "Contact",
    "text": "Contact\nFor questions about this analysis, please contact:\n[Your contact information here]"
  },
  {
    "objectID": "about.html#acknowledgments",
    "href": "about.html#acknowledgments",
    "title": "About This Project",
    "section": "Acknowledgments",
    "text": "Acknowledgments\n\nData collection and laboratory analysis: [Your team/institution]\nBioinformatics analysis: [Your name/team]\nComputational resources: [Institution/facility]"
  },
  {
    "objectID": "about.html#citation",
    "href": "about.html#citation",
    "title": "About This Project",
    "section": "Citation",
    "text": "Citation\nIf you use this analysis or data, please cite:\n[Your preferred citation format]"
  },
  {
    "objectID": "about.html#technical-notes",
    "href": "about.html#technical-notes",
    "title": "About This Project",
    "section": "Technical Notes",
    "text": "Technical Notes\n\nWebsite Generation\nThis website was created using: - Quarto (v1.4+) - Scientific and technical publishing system - GitHub Pages - Free static website hosting - R Markdown - Dynamic document generation\n\n\nRendering\nTo regenerate this website locally:\n# Install Quarto (https://quarto.org/docs/get-started/)\n\n# Clone the repository\ngit clone https://github.com/YOUR-USERNAME/YOUR-REPO-NAME.git\ncd YOUR-REPO-NAME\n\n# Render the website\nquarto render\n\n# Preview locally\nquarto preview\n\n\nSoftware Versions\n\nR: 4.5.1\nQuarto: 1.4+\nRStudio/Positron: 2025.12.2\n\n\nLast updated: December 27, 2025"
  },
  {
    "objectID": "WORKFLOW.html",
    "href": "WORKFLOW.html",
    "title": "",
    "section": "",
    "text": "Code"
  },
  {
    "objectID": "WORKFLOW.html#your-files-github-website",
    "href": "WORKFLOW.html#your-files-github-website",
    "title": "",
    "section": "Your Files â†’ GitHub â†’ Website",
    "text": "Your Files â†’ GitHub â†’ Website\nâ”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”\nâ”‚                    YOUR LOCAL COMPUTER                       â”‚\nâ”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤\nâ”‚                                                               â”‚\nâ”‚  ğŸ“ Your Project Folder                                      â”‚\nâ”‚  â”œâ”€â”€ index.qmd                    â† Homepage                 â”‚\nâ”‚  â”œâ”€â”€ resistome_analysis_report.qmd â† Full Report            â”‚\nâ”‚  â”œâ”€â”€ about.qmd                    â† About Page               â”‚\nâ”‚  â”œâ”€â”€ _quarto.yml                  â† Configuration            â”‚\nâ”‚  â”œâ”€â”€ styles.css                   â† Styling                  â”‚\nâ”‚  â””â”€â”€ Progetto 1 (KPC-31)...xlsx  â† Data                     â”‚\nâ”‚                                                               â”‚\nâ”‚  ğŸ’» Step 1: Edit files in Positron/RStudio                   â”‚\nâ”‚                                                               â”‚\nâ”‚  âš¡ Step 2: Run: quarto render                               â”‚\nâ”‚       â”‚                                                       â”‚\nâ”‚       â”œâ”€â†’ Creates docs/ folder with HTML files               â”‚\nâ”‚       â”‚                                                       â”‚\nâ”‚       â””â”€â†’ docs/                                              â”‚\nâ”‚           â”œâ”€â”€ index.html                                     â”‚\nâ”‚           â”œâ”€â”€ resistome_analysis_report.html                 â”‚\nâ”‚           â”œâ”€â”€ about.html                                     â”‚\nâ”‚           â””â”€â”€ (all plots, tables, etc.)                      â”‚\nâ”‚                                                               â”‚\nâ””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜\n                         â”‚\n                         â”‚ git push\n                         â†“\nâ”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”\nâ”‚                         GITHUB                               â”‚\nâ”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤\nâ”‚                                                               â”‚\nâ”‚  ğŸ™ Your Repository: username/kpc31-resistome-analysis      â”‚\nâ”‚                                                               â”‚\nâ”‚  main branch:                                                â”‚\nâ”‚  â”œâ”€â”€ All your .qmd files                                    â”‚\nâ”‚  â”œâ”€â”€ _quarto.yml                                            â”‚\nâ”‚  â””â”€â”€ docs/ â† GitHub Pages serves from here!                 â”‚\nâ”‚      â”œâ”€â”€ index.html                                         â”‚\nâ”‚      â”œâ”€â”€ resistome_analysis_report.html                     â”‚\nâ”‚      â””â”€â”€ ...                                                â”‚\nâ”‚                                                               â”‚\nâ””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜\n                         â”‚\n                         â”‚ GitHub Pages\n                         â”‚ (automatic)\n                         â†“\nâ”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”\nâ”‚                    LIVE WEBSITE ğŸŒ                          â”‚\nâ”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤\nâ”‚                                                               â”‚\nâ”‚  ğŸŒ https://username.github.io/kpc31-resistome-analysis/    â”‚\nâ”‚                                                               â”‚\nâ”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”               â”‚\nâ”‚  â”‚  ğŸ  Homepage                             â”‚               â”‚\nâ”‚  â”‚  â”œâ”€ Quick Summary                        â”‚               â”‚\nâ”‚  â”‚  â”œâ”€ Key Findings                         â”‚               â”‚\nâ”‚  â”‚  â””â”€ Links to Full Report                 â”‚               â”‚\nâ”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜               â”‚\nâ”‚                                                               â”‚\nâ”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”               â”‚\nâ”‚  â”‚  ğŸ“Š Full Report                          â”‚               â”‚\nâ”‚  â”‚  â”œâ”€ All analyses                         â”‚               â”‚\nâ”‚  â”‚  â”œâ”€ Interactive plots                    â”‚               â”‚\nâ”‚  â”‚  â”œâ”€ Tables                               â”‚               â”‚\nâ”‚  â”‚  â””â”€ Collapsible code                     â”‚               â”‚\nâ”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜               â”‚\nâ”‚                                                               â”‚\nâ”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”               â”‚\nâ”‚  â”‚  â„¹ï¸  About Page                          â”‚               â”‚\nâ”‚  â”‚  â”œâ”€ Methods                              â”‚               â”‚\nâ”‚  â”‚  â”œâ”€ Data sources                         â”‚               â”‚\nâ”‚  â”‚  â””â”€ Technical details                    â”‚               â”‚\nâ”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜               â”‚\nâ”‚                                                               â”‚\nâ”‚  Anyone can access this URL! ğŸ‰                             â”‚\nâ”‚                                                               â”‚\nâ””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜"
  },
  {
    "objectID": "WORKFLOW.html#update-workflow",
    "href": "WORKFLOW.html#update-workflow",
    "title": "",
    "section": "ğŸ”„ Update Workflow",
    "text": "ğŸ”„ Update Workflow\nEdit .qmd â†’ quarto render â†’ git push â†’ Website updates!\n   ğŸ“            âš¡             ğŸš€           âœ¨\n (2 min)      (1 min)       (1 min)    (1-2 min)"
  },
  {
    "objectID": "WORKFLOW.html#checklist",
    "href": "WORKFLOW.html#checklist",
    "title": "",
    "section": "ğŸ“‹ Checklist",
    "text": "ğŸ“‹ Checklist\n\nOne-Time Setup\n\nCreate GitHub repository\nEdit _quarto.yml (update username/repo)\nRun quarto render\nPush to GitHub\nEnable GitHub Pages in Settings\nWait 2 minutes\nVisit your website!\n\n\n\nEvery Update\n\nEdit files\nRun quarto render\ngit add . && git commit && git push\nWait 1-2 minutes\nRefresh website"
  },
  {
    "objectID": "WORKFLOW.html#key-points",
    "href": "WORKFLOW.html#key-points",
    "title": "",
    "section": "ğŸ¯ Key Points",
    "text": "ğŸ¯ Key Points\n\nEdit locally - Work on .qmd files in Positron\nRender locally - quarto render creates HTML\nPush to GitHub - Git uploads everything\nGitHub Pages - Automatically serves from docs/ folder\nWebsite updates - Takes 1-2 minutes to go live"
  },
  {
    "objectID": "WORKFLOW.html#data-privacy-options",
    "href": "WORKFLOW.html#data-privacy-options",
    "title": "",
    "section": "ğŸ”’ Data Privacy Options",
    "text": "ğŸ”’ Data Privacy Options\n\nOption 1: Keep Data Public\nâ””â”€â”€ Data included in GitHub (anyone can download)\n\n\nOption 2: Keep Data Private\n1. Uncomment *.xlsx in .gitignore\n2. git rm --cached \"*.xlsx\"\n3. Users need local copy to run code\n4. Website still shows all results (already rendered)"
  },
  {
    "objectID": "WORKFLOW.html#what-makes-this-special",
    "href": "WORKFLOW.html#what-makes-this-special",
    "title": "",
    "section": "ğŸŒŸ What Makes This Special",
    "text": "ğŸŒŸ What Makes This Special\n\nâœ… Free - GitHub Pages is free for public repos\nâœ… Fast - Updates in minutes\nâœ… Professional - Clean, modern design\nâœ… Interactive - All plots and tables work\nâœ… Mobile-friendly - Works on phones/tablets\nâœ… Shareable - Just share the URL\nâœ… Version controlled - Full history with git"
  },
  {
    "objectID": "WORKFLOW.html#tips",
    "href": "WORKFLOW.html#tips",
    "title": "",
    "section": "ğŸ’¡ Tips",
    "text": "ğŸ’¡ Tips\n\nUse quarto preview to see changes before pushing\nHard refresh (Ctrl+Shift+R) if changes donâ€™t show\nCheck GitHub Actions tab to see deployment status\nCustom domain possible (see GitHub Pages docs)\n\n\nNext: Open QUICKSTART.md for step-by-step commands!"
  },
  {
    "objectID": "QUICKSTART.html",
    "href": "QUICKSTART.html",
    "title": "",
    "section": "",
    "text": "Code"
  },
  {
    "objectID": "QUICKSTART.html#minute-setup",
    "href": "QUICKSTART.html#minute-setup",
    "title": "",
    "section": "5-Minute Setup",
    "text": "5-Minute Setup\n\n1ï¸âƒ£ Create GitHub Repository (2 min)\n1. Go to: https://github.com/new\n2. Name: kpc31-resistome-analysis\n3. Public âœ…\n4. Add README âœ…\n5. Click \"Create repository\"\n\n\n2ï¸âƒ£ Prepare Files (1 min)\n# In your terminal (where your files are):\ncd /path/to/your/project\n\n# Edit _quarto.yml line 13:\n# Change: YOUR-USERNAME to your GitHub username\n# Change: YOUR-REPO-NAME to kpc31-resistome-analysis\n\n# Render website\nquarto render\n\n\n3ï¸âƒ£ Push to GitHub (1 min)\ngit init\ngit add .\ngit commit -m \"Initial commit\"\ngit remote add origin https://github.com/YOUR-USERNAME/kpc31-resistome-analysis.git\ngit branch -M main\ngit push -u origin main\n\n\n4ï¸âƒ£ Enable GitHub Pages (1 min)\n1. Go to: https://github.com/YOUR-USERNAME/kpc31-resistome-analysis\n2. Click: Settings â†’ Pages\n3. Source: Deploy from a branch\n4. Branch: main\n5. Folder: /docs\n6. Save\n\n\nâœ… Done!\nYour site will be live in 1-2 minutes at:\nhttps://YOUR-USERNAME.github.io/kpc31-resistome-analysis/"
  },
  {
    "objectID": "QUICKSTART.html#to-update-website-later",
    "href": "QUICKSTART.html#to-update-website-later",
    "title": "",
    "section": "ğŸ”„ To Update Website Later",
    "text": "ğŸ”„ To Update Website Later\n# 1. Make your changes to .qmd files\n# 2. Re-render\nquarto render\n\n# 3. Push changes\ngit add .\ngit commit -m \"Update analysis\"\ngit push\nWebsite updates automatically in 1-2 minutes!"
  },
  {
    "objectID": "QUICKSTART.html#common-issues",
    "href": "QUICKSTART.html#common-issues",
    "title": "",
    "section": "â“ Common Issues",
    "text": "â“ Common Issues\nQ: Website shows 404? - A: Wait 2-3 minutes after first setup - Check Settings â†’ Pages shows â€œpublishedâ€\nQ: Changes not showing? - A: Did you run quarto render before pushing? - Try hard refresh: Ctrl+Shift+R (Windows) or Cmd+Shift+R (Mac)\nQ: How do I keep data private? - A: In .gitignore, uncomment: # *.xlsx - Then: git rm --cached \"*.xlsx\" and push"
  },
  {
    "objectID": "QUICKSTART.html#share-your-website",
    "href": "QUICKSTART.html#share-your-website",
    "title": "",
    "section": "ğŸ“± Share Your Website",
    "text": "ğŸ“± Share Your Website\nOnce live, share this link:\nhttps://YOUR-USERNAME.github.io/kpc31-resistome-analysis/\nThe website works on: - ğŸ’» Desktop browsers - ğŸ“± Mobile devices - ğŸ“Š Contains all interactive plots and tables - ğŸ” Searchable and navigable\n\nNeed detailed help? See README.md\nProblems? Check: https://quarto.org/docs/troubleshooting/"
  },
  {
    "objectID": "resistome_analysis_report.html",
    "href": "resistome_analysis_report.html",
    "title": "Comprehensive Resistome Analysis",
    "section": "",
    "text": "Note\n\n\n\nThis report was generated using AI under general human direction. At the time of generation, the contents have not been comprehensively reviewed by a human analyst."
  },
  {
    "objectID": "resistome_analysis_report.html#key-findings",
    "href": "resistome_analysis_report.html#key-findings",
    "title": "Comprehensive Resistome Analysis",
    "section": "Key Findings",
    "text": "Key Findings\n\n\n\n\n\n\nImportantCritical Discovery: Universal blaKPC-31 Carriage\n\n\n\nALL 42 isolates (100%) carry the blaKPC-31 carbapenemase gene, indicating this is a KPC-31-specific collection or outbreak. This variant is responsible for the observed carbapenem resistance and variable ceftazidime-avibactam (CAZ-AVI) resistance across isolates.\n\n\n\nDominant species: Klebsiella pneumoniae (78.6%, n=33)\nMost prevalent sequence type: ST307 (50% of typed isolates, n=16)\nHigh-risk clones identified: ST307, ST512, ST101, ST131, ST147\nCAZ-AVI resistance: 35.7% show high-level resistance (MIC &gt;16 mg/L)\nPlasmid diversity: 15 incompatibility groups, with IncF plasmids spreading across multiple clones"
  },
  {
    "objectID": "resistome_analysis_report.html#data-structure",
    "href": "resistome_analysis_report.html#data-structure",
    "title": "Comprehensive Resistome Analysis",
    "section": "1.1 Data Structure",
    "text": "1.1 Data Structure\n\n\nDataset Dimensions:\n\n\n==================\n\n\nâ€¢ Total isolates: 42\n\n\nâ€¢ Total variables: 155\n\n\nâ€¢ Antibiotics tested (MIC): ~26\n\n\nâ€¢ Resistance genes analyzed: 36\n\n\nâ€¢ Plasmid Inc groups detected: 15"
  },
  {
    "objectID": "resistome_analysis_report.html#data-completeness",
    "href": "resistome_analysis_report.html#data-completeness",
    "title": "Comprehensive Resistome Analysis",
    "section": "1.2 Data Completeness",
    "text": "1.2 Data Completeness\n\n\n\n\nTableÂ 1: Data completeness for key metadata variables\n\n\n\n\n\n\nVariable\nTotal\nComplete\nMissing\n% Complete\n\n\n\n\nID\n42\n42\n0\n100.0\n\n\nSpecies\n42\n42\n0\n100.0\n\n\nClinical Source\n42\n32\n10\n76.2\n\n\nSequence Type (ST)\n42\n32\n10\n76.2\n\n\nCapsular Type (KL)\n42\n10\n32\n23.8\n\n\nWzi Type\n42\n9\n33\n21.4"
  },
  {
    "objectID": "resistome_analysis_report.html#species-distribution",
    "href": "resistome_analysis_report.html#species-distribution",
    "title": "Comprehensive Resistome Analysis",
    "section": "2.1 Species Distribution",
    "text": "2.1 Species Distribution\n\n\n\n\n\n\n\n\nFigureÂ 1: Distribution of bacterial species in the collection\n\n\n\n\n\n\n\n\n\n\n\nNoteSpecies Composition\n\n\n\n\nKlebsiella pneumoniae: 33/42 isolates (78.6%)\nEscherichia coli variants: 9/42 isolates (21.4%)\n\nE. coli TOP10: 5 isolates (lab strain)\nE. coli DH5-Î±: 2 isolates (lab strain)\nE. coli: 2 isolates (clinical)"
  },
  {
    "objectID": "resistome_analysis_report.html#sequence-types-mlst",
    "href": "resistome_analysis_report.html#sequence-types-mlst",
    "title": "Comprehensive Resistome Analysis",
    "section": "2.2 Sequence Types (MLST)",
    "text": "2.2 Sequence Types (MLST)\n\n\n\n\n\n\n\n\nFigureÂ 2: Distribution of sequence types among typed isolates\n\n\n\n\n\n\n\n\n\nTableÂ 2: Summary of sequence types and their clinical significance\n\n\n\n\n\n\nST\nn\nPercentage\nSpecies\nClinical.Significance\n\n\n\n\nST307\n16\n50.0\nK. pneumoniae\nGlobal high-risk clone\n\n\nST101\n7\n21.9\nK. pneumoniae\nMDR clone\n\n\nST512\n5\n15.6\nK. pneumoniae\nEmerging high-risk clone\n\n\nST131\n2\n6.3\nE. coli\nGlobal E. coli pandemic clone\n\n\nST147\n2\n6.3\nK. pneumoniae\nMDR K. pneumoniae clone"
  },
  {
    "objectID": "resistome_analysis_report.html#clinical-sources",
    "href": "resistome_analysis_report.html#clinical-sources",
    "title": "Comprehensive Resistome Analysis",
    "section": "2.3 Clinical Sources",
    "text": "2.3 Clinical Sources\n\n\n\n\n\n\n\n\nFigureÂ 3: Distribution of clinical specimen types"
  },
  {
    "objectID": "resistome_analysis_report.html#capsular-types-kl",
    "href": "resistome_analysis_report.html#capsular-types-kl",
    "title": "Comprehensive Resistome Analysis",
    "section": "2.4 Capsular Types (KL)",
    "text": "2.4 Capsular Types (KL)\n\n\n\n\n\n\nImportantPerfect KL-ST Association\n\n\n\nEach capsular type is exclusively associated with one sequence type, suggesting stable clonal lineages:\n\nKL107 â†”ï¸ ST512 (n=4)\nKL102 â†”ï¸ ST307 (n=2)\nKL17 â†”ï¸ ST101 (n=2)\nKL64 â†”ï¸ ST147 (n=2)\n\nOnly 23.8% (10/42) of isolates have capsular typing data, but the perfect association is striking."
  },
  {
    "objectID": "resistome_analysis_report.html#ceftazidime-avibactam-caz-avi-resistance",
    "href": "resistome_analysis_report.html#ceftazidime-avibactam-caz-avi-resistance",
    "title": "Comprehensive Resistome Analysis",
    "section": "3.1 Ceftazidime-Avibactam (CAZ-AVI) Resistance",
    "text": "3.1 Ceftazidime-Avibactam (CAZ-AVI) Resistance\n\n\n\n\n\n\n\n\nFigureÂ 4: Distribution of CAZ-AVI MIC values"
  },
  {
    "objectID": "resistome_analysis_report.html#caz-avi-resistance-by-sequence-type",
    "href": "resistome_analysis_report.html#caz-avi-resistance-by-sequence-type",
    "title": "Comprehensive Resistome Analysis",
    "section": "3.2 CAZ-AVI Resistance by Sequence Type",
    "text": "3.2 CAZ-AVI Resistance by Sequence Type\n\n\n\n\n\n\n\n\nFigureÂ 5: CAZ-AVI resistance stratified by sequence type\n\n\n\n\n\n\n\n\n\n\n\nWarningST307 Heterogeneous Resistance\n\n\n\nST307 shows a 50/50 split between intermediate and resistant isolates, suggesting:\n\nEvolving resistance mechanisms within this clone\nPotential for further resistance development\nNeed for careful monitoring"
  },
  {
    "objectID": "resistome_analysis_report.html#multi-antibiotic-resistance-heatmap",
    "href": "resistome_analysis_report.html#multi-antibiotic-resistance-heatmap",
    "title": "Comprehensive Resistome Analysis",
    "section": "3.3 Multi-Antibiotic Resistance Heatmap",
    "text": "3.3 Multi-Antibiotic Resistance Heatmap\n\n\n\n\n\n\n\n\nFigureÂ 6: Median MIC values across antibiotics by sequence type"
  },
  {
    "objectID": "resistome_analysis_report.html#blakpc-31-the-universal-carbapenemase",
    "href": "resistome_analysis_report.html#blakpc-31-the-universal-carbapenemase",
    "title": "Comprehensive Resistome Analysis",
    "section": "4.1 blaKPC-31: The Universal Carbapenemase",
    "text": "4.1 blaKPC-31: The Universal Carbapenemase\n\n\n\n\n\n\n\n\nFigureÂ 7: blaKPC-31 prevalence across species and sequence types\n\n\n\n\n\n\n\n\n\n\n\nImportantUniversal KPC-31 Carriage\n\n\n\n100% of isolates (42/42) carry blaKPC-31, including:\n\nAll K. pneumoniae isolates\nAll E. coli isolates (including lab strains)\nAll sequence types\nBoth clinical and environmental isolates\n\nThis indicates a KPC-31-specific collection or outbreak."
  },
  {
    "objectID": "resistome_analysis_report.html#resistance-gene-profiles-by-clone",
    "href": "resistome_analysis_report.html#resistance-gene-profiles-by-clone",
    "title": "Comprehensive Resistome Analysis",
    "section": "4.2 Resistance Gene Profiles by Clone",
    "text": "4.2 Resistance Gene Profiles by Clone\n\n\n\n\n\n\n\n\nFigureÂ 8: Resistance gene profiles for isolates with capsular typing\n\n\n\n\n\n\n\n\n\nTableÂ 3: Summary of resistance genes by KL/ST combination\n\n\n\n\n\n\nClone\nTotal.Genes\nBeta.lactamases\nKey.Features\n\n\n\n\nKL64 (ST147)\n15\nKPC-31, CTX-M-15, TEM-1B, SHV-11, OXA-1\nMost genes; fosfomycin resistance\n\n\nKL102 (ST307)\n13\nKPC-31, CTX-M-15, TEM-1B, SHV-28, OXA-1\nqnrB1 quinolone resistance\n\n\nKL107 (ST512)\n12\nKPC-31, TEM-1A, SHV-158\nIncX3 plasmid-associated\n\n\nKL17 (ST101)\n5\nKPC-31, SHV-1\narmA (pan-AMG resistance)\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nNoteNotable Findings\n\n\n\n\nKL64 (ST147): Highest gene count (15), includes fosA (fosfomycin resistance)\nKL17 (ST101): Lowest gene count (5), but includes armA conferring pan-aminoglycoside resistance\nKL102 (ST307): Carries qnrB1 providing quinolone resistance\nKL107 (ST512): Associated with IncX3 plasmid"
  },
  {
    "objectID": "resistome_analysis_report.html#kl-st-perfect-association",
    "href": "resistome_analysis_report.html#kl-st-perfect-association",
    "title": "Comprehensive Resistome Analysis",
    "section": "5.1 KL-ST Perfect Association",
    "text": "5.1 KL-ST Perfect Association\n\n\n\n\n\n\n\n\nFigureÂ 9: Perfect 1:1 association between capsular types and sequence types"
  },
  {
    "objectID": "resistome_analysis_report.html#caz-avi-resistance-by-capsular-type",
    "href": "resistome_analysis_report.html#caz-avi-resistance-by-capsular-type",
    "title": "Comprehensive Resistome Analysis",
    "section": "5.2 CAZ-AVI Resistance by Capsular Type",
    "text": "5.2 CAZ-AVI Resistance by Capsular Type\n\n\n\n\n\n\n\n\nFigureÂ 10: CAZ-AVI resistance profiles differ dramatically by capsular type\n\n\n\n\n\n\n\n\n\nTableÂ 4: CAZ-AVI resistance profiles by capsular type\n\n\n\n\n\n\nKL.Type\nST\nn\nMedian.MIC\nResistance.Status\nClinical.Concern\n\n\n\n\nKL64\nST147\n2\n256\n100% Resistant\nVery High\n\n\nKL17\nST101\n2\n130\n100% Resistant\nVery High\n\n\nKL107\nST512\n4\n48\n100% Resistant\nHigh\n\n\nKL102\nST307\n2\n12\n100% Intermediate\nModerate"
  },
  {
    "objectID": "resistome_analysis_report.html#inc-group-distribution",
    "href": "resistome_analysis_report.html#inc-group-distribution",
    "title": "Comprehensive Resistome Analysis",
    "section": "6.1 Inc Group Distribution",
    "text": "6.1 Inc Group Distribution\n\n\n\n\n\n\n\n\nFigureÂ 11: Prevalence of major incompatibility groups"
  },
  {
    "objectID": "resistome_analysis_report.html#inc-groups-by-clone",
    "href": "resistome_analysis_report.html#inc-groups-by-clone",
    "title": "Comprehensive Resistome Analysis",
    "section": "6.2 Inc Groups by Clone",
    "text": "6.2 Inc Groups by Clone\n\n\n\n\n\n\n\n\nFigureÂ 12: Incompatibility group distribution by KL/ST combination\n\n\n\n\n\n\n\n\n\n\n\nImportantClone-Specific Plasmid Profiles\n\n\n\n\nKL107 (ST512): IncX3 (100%) - fixed, likely carries blaKPC-31\nKL17 (ST101): IncR (50%) - may carry armA gene\nKL64 (ST147): IncF family (50%) - high HGT potential\nKL102 (ST307): NO Inc groups detected - chromosomal integration?"
  },
  {
    "objectID": "resistome_analysis_report.html#horizontal-gene-transfer-evidence",
    "href": "resistome_analysis_report.html#horizontal-gene-transfer-evidence",
    "title": "Comprehensive Resistome Analysis",
    "section": "6.3 Horizontal Gene Transfer Evidence",
    "text": "6.3 Horizontal Gene Transfer Evidence\n\n\n\n\n\n\n\n\nFigureÂ 13: Plasmid diversity indicates horizontal gene transfer potential\n\n\n\n\n\n\n\n\n\nTableÂ 5: Evidence for horizontal gene transfer by Inc group\n\n\n\n\n\n\nInc.Group\nDistribution\nHGT.Evidence\nSignificance\n\n\n\n\nIncFIB(K) / IncFII(K)\n4 different STs\nâ˜…â˜…â˜…â˜…â˜… High\nActive dissemination within K. pneumoniae\n\n\nIncX3\nST512 only\nâ˜…â˜†â˜†â˜†â˜† None\nClone-specific, stable, not spreading\n\n\nIncR\nPrimarily ST101\nâ˜…â˜…â˜†â˜†â˜† Limited\nMay carry armA, limited to one clone\n\n\nIncN\nRare, isolated\nâ˜…â˜…â˜…â˜†â˜† Moderate\nRecent acquisition, broad host range potential"
  },
  {
    "objectID": "resistome_analysis_report.html#relationships-between-plasmids-genes-and-resistance",
    "href": "resistome_analysis_report.html#relationships-between-plasmids-genes-and-resistance",
    "title": "Comprehensive Resistome Analysis",
    "section": "7.1 Relationships Between Plasmids, Genes, and Resistance",
    "text": "7.1 Relationships Between Plasmids, Genes, and Resistance\n\n\n\n\n\n\n\n\nFigureÂ 14: Integrated view of plasmid complexity, gene burden, and resistance levels\n\n\n\n\n\n\n\n\n\n\n\nNoteKey Paradoxes\n\n\n\n\nKL102 (ST307): Zero Inc groups but 13 resistance genes â†’ Chromosomal integration?\nKL17 (ST101): High plasmid complexity (2.3) but only 5 genes â†’ Quality over quantity (armA effect)\nKL64 (ST147): Most genes (15) and highest MIC (256) â†’ Synergistic effects"
  },
  {
    "objectID": "resistome_analysis_report.html#summary-table-clone-characteristics",
    "href": "resistome_analysis_report.html#summary-table-clone-characteristics",
    "title": "Comprehensive Resistome Analysis",
    "section": "7.2 Summary Table: Clone Characteristics",
    "text": "7.2 Summary Table: Clone Characteristics\n\n\n\n\nTableÂ 6: Comprehensive summary of clone characteristics\n\n\n\n\n\n\nClone\nn\nCAZ.AVI\nResistance.Genes\nKey.Genes\nDominant.Plasmid\nHGT.Risk\nClinical.Priority\n\n\n\n\nKL107 (ST512)\n4\nResistant (48)\n12\nblaKPC-31, blaTEM-1A\nIncX3 (100%)\nLow\nHigh\n\n\nKL17 (ST101)\n2\nResistant (130)\n5\nblaKPC-31, armA\nIncR (50%)\nLow\nVery High\n\n\nKL64 (ST147)\n2\nResistant (256)\n15\nblaKPC-31, CTX-M-15, fosA\nIncF (50%)\nHigh\nVery High\n\n\nKL102 (ST307)\n2\nIntermediate (12)\n13\nblaKPC-31, CTX-M-15, qnrB1\nNone detected\nUnknown\nMonitor"
  },
  {
    "objectID": "resistome_analysis_report.html#treatment-challenges",
    "href": "resistome_analysis_report.html#treatment-challenges",
    "title": "Comprehensive Resistome Analysis",
    "section": "8.1 Treatment Challenges",
    "text": "8.1 Treatment Challenges\n\n\n\n\n\n\nWarningExtremely Limited Treatment Options\n\n\n\nAll isolates carry blaKPC-31, resulting in:\n\nâœ— Carbapenems: Compromised by carbapenemase\nâš ï¸ CAZ-AVI: Variable resistance (35.7% high-level)\nâš ï¸ Aminoglycosides: Compromised (especially ST101 with armA)\nâš ï¸ Quinolones: Resistance common (gyrA, ParC, qnrB1)\n\n\n\n\n8.1.1 Potential Treatment Strategies\n\n\n\n\nTableÂ 7: Potential treatment options by clone type\n\n\n\n\n\n\nClone\nFirst.Line\nSecond.Line\nLast.Resort\nNotes\n\n\n\n\nKL107 (ST512)\nCefiderocol\nCarbapenem + AVI\nColistin\nIncX3-stable resistance\n\n\nKL17 (ST101)\nCefiderocol\nPlazomicin (not armA)\nColistin\narmA limits aminoglycosides\n\n\nKL64 (ST147)\nCombination therapy\nCarbapenem + fosfomycin\nColistin\nHigh gene burden, test all options\n\n\nKL102 (ST307)\nCarbapenems\nCAZ-AVI\nColistin\nBest prognosis of 4 clones"
  },
  {
    "objectID": "resistome_analysis_report.html#infection-control-priorities",
    "href": "resistome_analysis_report.html#infection-control-priorities",
    "title": "Comprehensive Resistome Analysis",
    "section": "8.2 Infection Control Priorities",
    "text": "8.2 Infection Control Priorities\n\n8.2.1 High-Risk Clones for Isolation\n\nST512 (KL107): IncX3 plasmid stable but high resistance\nST101 (KL17): armA-mediated pan-aminoglycoside resistance\nST147 (KL64): IncF plasmids with high HGT potential\n\n\n\n8.2.2 Surveillance Recommendations\n\n\n\n\n\nPriority\nTarget\nRationale\n\n\n\n\nCritical\nIncF plasmid spread\nSpreading across 4 STs, HGT evidence\n\n\nCritical\nblaKPC-31 variants\nMonitor for evolution (KPC-32, KPC-33, etc.)\n\n\nHigh\nST307 mechanism\nNo Inc groups detected - chromosomal integration?\n\n\nHigh\nCapsular typing\nStrong predictor of resistance phenotype\n\n\nModerate\nCAZ-AVI MICs\nEarly detection of resistance evolution"
  },
  {
    "objectID": "resistome_analysis_report.html#key-findings-summary",
    "href": "resistome_analysis_report.html#key-findings-summary",
    "title": "Comprehensive Resistome Analysis",
    "section": "9.1 Key Findings Summary",
    "text": "9.1 Key Findings Summary\n\nUniversal blaKPC-31 carriage (100%, 42/42) defines this collection\nST307 is dominant (50% of typed isolates) but shows heterogeneous resistance\nPerfect KL-ST associations indicate stable clonal lineages\nIncF plasmids are disseminating across multiple K. pneumoniae clones\nClone-specific resistance mechanisms:\n\nST512: IncX3-based (stable, not spreading)\nST101: IncR-based (armA-mediated pan-AMG resistance)\nST147: IncF-based (high HGT risk)\nST307: Unknown mechanism (requires investigation)"
  },
  {
    "objectID": "resistome_analysis_report.html#critical-questions-for-further-investigation",
    "href": "resistome_analysis_report.html#critical-questions-for-further-investigation",
    "title": "Comprehensive Resistome Analysis",
    "section": "9.2 Critical Questions for Further Investigation",
    "text": "9.2 Critical Questions for Further Investigation\n\n\n\n\n\n\nTipRecommended Next Steps\n\n\n\n\nWhole plasmid sequencing: Map complete genetic context of resistance genes\nST307 mechanism: Investigate chromosomal vs cryptic plasmid integration\nIncX3 plasmid characterization: Complete sequence of ST512 blaKPC-31-bearing plasmid\nTemporal analysis: If collection dates available, track resistance evolution\nEpidemiological links: Investigate patient/ward connections for transmission chains\nFunctional studies: Test plasmid transferability and fitness costs"
  },
  {
    "objectID": "resistome_analysis_report.html#public-health-implications",
    "href": "resistome_analysis_report.html#public-health-implications",
    "title": "Comprehensive Resistome Analysis",
    "section": "9.3 Public Health Implications",
    "text": "9.3 Public Health Implications\n\n\n\n\n\n\nImportantOutbreak Potential\n\n\n\nThis collection represents either:\n\nA KPC-31-specific outbreak with multiple introductions\nA surveillance collection of endemic KPC-31 strains\nClonal expansion of resistant lineages with horizontal gene transfer\n\nThe presence of high-risk global clones (ST307, ST512, ST101, ST131, ST147) combined with active plasmid dissemination (IncF family) represents a significant public health concern requiring immediate infection control measures."
  },
  {
    "objectID": "resistome_analysis_report.html#data-source",
    "href": "resistome_analysis_report.html#data-source",
    "title": "Comprehensive Resistome Analysis",
    "section": "10.1 Data Source",
    "text": "10.1 Data Source\n\nDataset: Progetto 1 (KPC-31) versione 2.xlsx\n42 bacterial isolates\n155 variables including:\n\nBacterial identification (species, MLST, capsular typing)\nAntimicrobial susceptibility testing (MIC for ~26 antibiotics)\nResistance gene detection (36 genes)\nPlasmid replicon typing (15 incompatibility groups)"
  },
  {
    "objectID": "resistome_analysis_report.html#analytical-approach",
    "href": "resistome_analysis_report.html#analytical-approach",
    "title": "Comprehensive Resistome Analysis",
    "section": "10.2 Analytical Approach",
    "text": "10.2 Analytical Approach\nAll analyses were performed using R version 4.5.1 with the following packages:\n\ntidyverse for data manipulation and visualization\nreadxl for Excel file import\nggplot2 for graphics\nknitr and kableExtra for tables\n\n\n10.2.1 Resistance Categorization\n\nCAZ-AVI Susceptible: MIC â‰¤8 mg/L\nCAZ-AVI Intermediate: MIC 9-16 mg/L\nCAZ-AVI Resistant: MIC &gt;16 mg/L\n\n\n\n10.2.2 Statistical Notes\n\nPercentages calculated on non-missing values\nMedian MIC used for heatmaps to reduce outlier effects\nLog2 transformation applied for MIC visualization"
  },
  {
    "objectID": "resistome_analysis_report.html#complete-resistance-gene-list",
    "href": "resistome_analysis_report.html#complete-resistance-gene-list",
    "title": "Comprehensive Resistome Analysis",
    "section": "11.1 Complete Resistance Gene List",
    "text": "11.1 Complete Resistance Gene List\n\n\n\n\nTableÂ 8: Complete list of resistance genes detected in the dataset\n\n\n\n\n\n\nCategory\nGene\nMechanism\n\n\n\n\nBeta-lactamases\n\n\nBeta-lactamases\nBlaKPC-31\nCarbapenemase (KPC)\n\n\nBeta-lactamases\nBlaCTXM-15\nESBL (CTX-M)\n\n\nBeta-lactamases\nblaTEM-1A\nBeta-lactamase (TEM)\n\n\nBeta-lactamases\nblaTEM-1B\nBeta-lactamase (TEM)\n\n\nBeta-lactamases\nblaSHV-1\nBeta-lactamase (SHV)\n\n\nBeta-lactamases\nblaSHV-11\nBeta-lactamase (SHV)\n\n\nBeta-lactamases\nblaSHV-28\nBeta-lactamase (SHV)\n\n\nBeta-lactamases\nBlaSHV-106\nBeta-lactamase (SHV)\n\n\nBeta-lactamases\nBlaSHV-158\nBeta-lactamase (SHV)\n\n\nBeta-lactamases\nblaOXA-1\nBeta-lactamase (OXA)\n\n\nBeta-lactamases\nbla OXA-9\nBeta-lactamase (OXA)\n\n\nAminoglycosides\n\n\nAminoglycosides\naadA\nAminoglycoside acetyltransferase\n\n\nAminoglycosides\naaaA2\nAminoglycoside resistance\n\n\nAminoglycosides\naac(6â€²)-Ib'\nAminoglycoside acetyltransferase\n\n\nAminoglycosides\naac(6Â´)-Ib-cr\nAMG + FQ resistance\n\n\nAminoglycosides\nant(2â€²')-Ia\nAminoglycoside nucleotidyltransferase\n\n\nAminoglycosides\naac(3)-IIa\nAminoglycoside acetyltransferase\n\n\nAminoglycosides\narmA\n16S rRNA methylase (pan-AMG)\n\n\nAminoglycosides\naph(3')-Ia\nAminoglycoside phosphotransferase\n\n\nQuinolones\n\n\nQuinolones\nParC\nDNA gyrase mutation\n\n\nQuinolones\ngyrA\nDNA gyrase mutation\n\n\nQuinolones\nqnrB1\nQuinolone resistance\n\n\nOther Mechanisms\n\n\nOther\nSul1\nSulfonamide resistance\n\n\nOther\nSul2\nSulfonamide resistance\n\n\nOther\nfosA\nFosfomycin resistance"
  },
  {
    "objectID": "resistome_analysis_report.html#abbreviations",
    "href": "resistome_analysis_report.html#abbreviations",
    "title": "Comprehensive Resistome Analysis",
    "section": "11.2 Abbreviations",
    "text": "11.2 Abbreviations\n\nAMG: Aminoglycoside\nCAZ-AVI: Ceftazidime-avibactam\nESBL: Extended-spectrum beta-lactamase\nHGT: Horizontal gene transfer\nInc: Incompatibility\nKL: Capsular type (K locus)\nMDR: Multi-drug resistant\nMIC: Minimum inhibitory concentration\nMLST: Multi-locus sequence typing\nST: Sequence type"
  },
  {
    "objectID": "resistome_analysis_report.html#session-information",
    "href": "resistome_analysis_report.html#session-information",
    "title": "Comprehensive Resistome Analysis",
    "section": "11.3 Session Information",
    "text": "11.3 Session Information\n\n\nCode\nsessionInfo()\n\n\nR version 4.5.1 (2025-06-13)\nPlatform: aarch64-apple-darwin20\nRunning under: macOS Tahoe 26.3\n\nMatrix products: default\nBLAS:   /Library/Frameworks/R.framework/Versions/4.5-arm64/Resources/lib/libRblas.0.dylib \nLAPACK: /Library/Frameworks/R.framework/Versions/4.5-arm64/Resources/lib/libRlapack.dylib;  LAPACK version 3.12.1\n\nlocale:\n[1] C.UTF-8/C.UTF-8/C.UTF-8/C/C.UTF-8/C.UTF-8\n\ntime zone: Europe/Rome\ntzcode source: internal\n\nattached base packages:\n[1] stats     graphics  grDevices utils     datasets  methods   base     \n\nother attached packages:\n [1] kableExtra_1.4.0 knitr_1.50       readxl_1.4.5     lubridate_1.9.4 \n [5] forcats_1.0.1    stringr_1.6.0    dplyr_1.1.4      purrr_1.2.0     \n [9] readr_2.1.6      tidyr_1.3.1      tibble_3.3.0     ggplot2_4.0.1   \n[13] tidyverse_2.0.0 \n\nloaded via a namespace (and not attached):\n [1] gtable_0.3.6       jsonlite_2.0.0     compiler_4.5.1     tidyselect_1.2.1  \n [5] xml2_1.5.1         textshaping_1.0.4  systemfonts_1.3.1  scales_1.4.0      \n [9] yaml_2.3.12        fastmap_1.2.0      R6_2.6.1           labeling_0.4.3    \n[13] generics_0.1.4     htmlwidgets_1.6.4  svglite_2.2.2      pillar_1.11.1     \n[17] RColorBrewer_1.1-3 tzdb_0.5.0         rlang_1.1.6        stringi_1.8.7     \n[21] xfun_0.55          S7_0.2.1           viridisLite_0.4.2  timechange_0.3.0  \n[25] cli_3.6.5          withr_3.0.2        magrittr_2.0.4     digest_0.6.39     \n[29] grid_4.5.1         rstudioapi_0.17.1  hms_1.1.4          lifecycle_1.0.4   \n[33] vctrs_0.6.5        evaluate_1.0.5     glue_1.8.0         cellranger_1.1.0  \n[37] farver_2.1.2       rmarkdown_2.30     tools_4.5.1        pkgconfig_2.0.3   \n[41] htmltools_0.5.9   \n\n\n\nReport generated on: December 27, 2025\nAnalysis platform: Positron 2025.12.2 with R 4.5.1"
  },
  {
    "objectID": "index.html",
    "href": "index.html",
    "title": "KPC-31 Resistome Analysis Project",
    "section": "",
    "text": "This website presents a comprehensive genomic and phenotypic analysis of 42 bacterial isolates from the KPC-31 resistome project. The collection includes carbapenemase-producing Klebsiella pneumoniae and Escherichia coli isolates with detailed molecular characterization.\n\n\n\n\n\n\nImportantCritical Finding\n\n\n\nALL 42 isolates (100%) carry the blaKPC-31 carbapenemase gene, making this a KPC-31-specific collection with significant clinical and epidemiological implications."
  },
  {
    "objectID": "index.html#welcome",
    "href": "index.html#welcome",
    "title": "KPC-31 Resistome Analysis Project",
    "section": "",
    "text": "This website presents a comprehensive genomic and phenotypic analysis of 42 bacterial isolates from the KPC-31 resistome project. The collection includes carbapenemase-producing Klebsiella pneumoniae and Escherichia coli isolates with detailed molecular characterization.\n\n\n\n\n\n\nImportantCritical Finding\n\n\n\nALL 42 isolates (100%) carry the blaKPC-31 carbapenemase gene, making this a KPC-31-specific collection with significant clinical and epidemiological implications."
  },
  {
    "objectID": "index.html#quick-summary",
    "href": "index.html#quick-summary",
    "title": "KPC-31 Resistome Analysis Project",
    "section": "Quick Summary",
    "text": "Quick Summary\n\n\n\nDataset Overview\n\n42 bacterial isolates\n155 variables analyzed\n26 antibiotics tested\n36 resistance genes detected\n15 plasmid Inc groups identified\n\n\n\n\nKey Findings\n\n78.6% K. pneumoniae\nST307 most prevalent (50%)\n100% blaKPC-31 positive\nHigh CAZ-AVI resistance (35.7%)\nActive plasmid dissemination"
  },
  {
    "objectID": "index.html#analysis-sections",
    "href": "index.html#analysis-sections",
    "title": "KPC-31 Resistome Analysis Project",
    "section": "Analysis Sections",
    "text": "Analysis Sections\n\nFull Report\nAccess the complete analysis including:\n\nBacterial Characterization: Species distribution, sequence types (ST), capsular types (KL)\nResistance Phenotypes: MIC distributions for 26 antibiotics, resistance patterns by clone\nResistance Genotypes: Comprehensive gene profiling, blaKPC-31 analysis\nPlasmid Analysis: Incompatibility groups, horizontal gene transfer evidence\nClinical Implications: Treatment recommendations, infection control priorities"
  },
  {
    "objectID": "index.html#highlights",
    "href": "index.html#highlights",
    "title": "KPC-31 Resistome Analysis Project",
    "section": "Highlights",
    "text": "Highlights\n\nSpecies DistributionHigh-Risk ClonesPlasmid FindingsClinical Impact\n\n\nKlebsiella pneumoniae dominates the collection (78.6%, n=33), with E. coli variants comprising 21.4%.\n\n\nFive high-risk sequence types identified: - ST307 (n=16): Global high-risk clone with heterogeneous resistance - ST512 (n=5): IncX3 plasmid-associated, 100% CAZ-AVI resistant - ST101 (n=7): armA-mediated pan-aminoglycoside resistance - ST147 (n=2): IncF plasmids with high HGT potential - ST131 (n=2): E. coli pandemic clone\n\n\n\nIncF plasmids spreading across 4 different sequence types\nIncX3 fixed in ST512 (100% prevalence)\n62% of isolates have no detectable Inc groups (chromosomal integration?)\n\n\n\nLimited treatment options due to: - Universal blaKPC-31 carriage - Variable CAZ-AVI resistance (35.7% high-level) - Multiple resistance mechanisms per isolate - Active horizontal gene transfer"
  },
  {
    "objectID": "index.html#key-visualizations",
    "href": "index.html#key-visualizations",
    "title": "KPC-31 Resistome Analysis Project",
    "section": "Key Visualizations",
    "text": "Key Visualizations\nThe full report contains interactive visualizations showing:\n\nSpecies and sequence type distributions\nCAZ-AVI resistance patterns by clone\nMulti-antibiotic resistance heatmaps\nResistance gene profiles\nPlasmid incompatibility group networks\nIntegrated analysis of plasmids, genes, and phenotypes"
  },
  {
    "objectID": "index.html#study-significance",
    "href": "index.html#study-significance",
    "title": "KPC-31 Resistome Analysis Project",
    "section": "Study Significance",
    "text": "Study Significance\nThis analysis reveals:\n\nUniversal blaKPC-31 dissemination across multiple high-risk clones\nPerfect KL-ST associations indicating stable clonal lineages\nClone-specific resistance mechanisms (plasmid-based vs chromosomal)\nActive horizontal gene transfer of IncF plasmids within K. pneumoniae\nUrgent need for infection control measures\n\n\n\n\n\n\n\nWarningPublic Health Concern\n\n\n\nThe combination of high-risk global clones (ST307, ST512, ST101, ST131, ST147) with active plasmid dissemination represents a significant public health threat requiring immediate intervention."
  },
  {
    "objectID": "index.html#navigation",
    "href": "index.html#navigation",
    "title": "KPC-31 Resistome Analysis Project",
    "section": "Navigation",
    "text": "Navigation\n\nFull Report: Complete analysis with all figures and tables\nAbout: Methods, data sources, and technical details\n\n\nLast updated: December 27, 2025"
  }
]